caa a22 4500 60615728X CHVBK 20210128100612.0 cr unu---uuuuu 210128e20150801xx s 000 0 eng 10.1007/s10096-015-2396-8 doi (NATIONALLICENCE)springer-10.1007/s10096-015-2396-8 Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities [Elektronische Daten] [D. Lepelletier, J. Lucet, P. Astagneau, B. Coignard, S. Vaux, C. Rabaud, B. Grandbastien, P. Berthelot] We performed a multicenter survey in May-June 2012 to assess strategies in preventing the spread of emerging extensively drug-resistant organisms (eXDRO), including glycopeptide-resistant enterococci and carbapenemase-producing Enterobacteriaceae, in a convenient sample of French healthcare facilities (HCFs). The collected data included organization and measures to: (1) identify patients at risk for carrying eXDRO, (2) investigate and control sporadic cases or outbreaks, and (3) describe prior 2010-2012 episodes with one or more colonized patients. Of the 286 participating HCFs, 163 (57%) and 134 (47%) reported having a specific procedure to detect repatriates or patients hospitalized in foreign countries within the last year, respectively. Among the 97 HCFs with prior at-risk patient management experience, contact precautions, hospitalization in a single room, and screening for eXDRO carriage were quasi-systematically performed (n = 92/97, 95%). The alleged time between admission and alert ranged from 24 to 48h after the patient's admission; 203 (71%) HCFs recommended obtaining three successive negative screening samples to declare a patient free of eXDRO colonization. During the last two years, 64 HCFs (23%) had to manage at least one eXDRO case, with a total of 20 outbreaks with more than one secondary case. This first national survey shows that French HCFs were not totally ready to control eXDRO spread in 2012. Their previous experiences and capacities in controlling eXDRO outbreaks are quite heterogeneous from one hospital to another. Further researches are needed in order to understand the constraints in applying national guidance. Springer-Verlag Berlin Heidelberg, 2015 Lepelletier D. Bacteriology and Infection Control Department, Nantes University Hospital, 44093, Nantes, France aut Lucet J. Infection Control Unit, AP-HP, Bichat-Claude Bernard Hospital, 75018, Paris, France aut Astagneau P. Paris-Nord inter-regional Center for Infection Control, 75013, Paris, France aut Coignard B. Infectious Diseases Department, National Institute of Health, 94415, Saint Maurice, France aut Vaux S. Infectious Diseases Department, National Institute of Health, 94415, Saint Maurice, France aut Rabaud C. Infectious Diseases Department, Nancy University Hospital, 54035, Nancy, France aut Grandbastien B. Infection Control Unit, Lille University Hospital, 59000, Lille, France aut Berthelot P. Infection Control Unit, Saint-Etienne University Hospital, 42000, Saint-Etienne, France aut European Journal of Clinical Microbiology & Infectious Diseases Springer Berlin Heidelberg 34/8(2015-08-01), 1615-1620 0934-9723 34:8<1615 2015 34 10096 https://doi.org/10.1007/s10096-015-2396-8 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10096-015-2396-8 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Lepelletier D. Bacteriology and Infection Control Department, Nantes University Hospital, 44093, Nantes, France aut NATIONALLICENCE 700 1- Lucet J. Infection Control Unit, AP-HP, Bichat-Claude Bernard Hospital, 75018, Paris, France aut NATIONALLICENCE 700 1- Astagneau P. Paris-Nord inter-regional Center for Infection Control, 75013, Paris, France aut NATIONALLICENCE 700 1- Coignard B. Infectious Diseases Department, National Institute of Health, 94415, Saint Maurice, France aut NATIONALLICENCE 700 1- Vaux S. Infectious Diseases Department, National Institute of Health, 94415, Saint Maurice, France aut NATIONALLICENCE 700 1- Rabaud C. Infectious Diseases Department, Nancy University Hospital, 54035, Nancy, France aut NATIONALLICENCE 700 1- Grandbastien B. Infection Control Unit, Lille University Hospital, 59000, Lille, France aut NATIONALLICENCE 700 1- Berthelot P. Infection Control Unit, Saint-Etienne University Hospital, 42000, Saint-Etienne, France aut NATIONALLICENCE 773 0- European Journal of Clinical Microbiology & Infectious Diseases Springer Berlin Heidelberg 34/8(2015-08-01), 1615-1620 0934-9723 34:8<1615 2015 34 10096